Visalytics
Visalytics
approved EB-2 (NIW)

Postdoctoral Scholar

Biotechnologies · Nepal · 2023-02-07

Processing Time
112 days
Decision Date
2023-02-07
Location
Ohio
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue research on utilizing biomedical engineering in cancer research and development to improve health outcomes for patients. The work focuses on nanotechnology for drug delivery, the exploration of circulating tumor cells (CTCs), and the creation of microfluidic models to inform metastasis research.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The research addresses cancer, a primary cause of death globally, and utilizes nanotechnology to interact with biomolecules throughout the body.

2 Well-positioned to Advance the Endeavor Met

The petitioner has 8 years of experience, 14 publications, 272 citations, and has secured funding from multiple international research councils.

3 Waiver of Job Offer and Labor Certification Met

It was determined that the petitioner's unique drug carrier and advances in biomedical engineering make his continued work beneficial to U.S. scientific interests.

Why This Petition Was Approved

The petition was approved based on the petitioner's 14 peer-reviewed journal and conference articles (6 first-authored) and 272 citations. Additional evidence included 8 years of research experience, editorial board membership, 2 peer reviews completed, and funding from international agencies like the Singapore MOE and the University Grants Commission of Nepal.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Grants
Original Contributions
Judging Experience

Similar Cases

Research Fellow

Biotechnology · India

WeGreened EB-2 (NIW) approved
Florida 48 days 2025-09-04
The petitioner proposes to develop precision oncology tools by integrating nanotechnology, immunology, and computational methods to engineer next-generation cancer therapies. His work specifically focuses on designing personalized, neoantigen-based nano vaccines and SMART-lipid nanoparticles to improve immune system responsiveness and overcome tumor immune evasion.
View Case

Research Scientist

Biotechnology · Iran

WeGreened EB-2 (NIW) approved
162 days 2025-04-17
The petitioner proposes to continue his research in molecular biomedicine, specifically focusing on the development of nanoparticle-based delivery systems. His work aims to improve targeted cancer therapies, including chemotherapy, immunotherapy, and tumor thermal therapy, to enhance therapeutic efficacy while reducing side effects. The intended impact is to advance cancer care and oncology breakthroughs within the U.S. healthcare system.
View Case

Consultant

Biotechnology · Turkey

WeGreened EB-2 (NIW) approved
2 days 2023-08-24
The petitioner proposes to continue research on developing cutting-edge nanotherapeutic and nanotheranostic systems, as well as toxicology assays. This work focuses on improving cancer diagnosis and treatment while evaluating and reducing the toxicity of biomedical materials and devices.
View Case

Engineer

Materials Science · China

WeGreened EB-2 (NIW) approved
California 6 days 2023-08-02
The petitioner proposes to investigate the biomedical applications of advanced biomaterials and manufacturing technologies to develop tissue substitutes for regenerative medicine. This work aims to create tumor models for cancer study to improve the outcomes of preclinical trials, diagnosis, and treatment.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Biotechnology cases More cases from Nepal

Case data sourced from publicly available petition decisions and case studies. Decision date: 2023-02-07.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 112 days
Criteria Met 3 / 3
Evidence Types 5

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,895
Success Rate 54.2%
Sustained 2,112
Dismissed 1,687

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in Nepal All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist